Please use this identifier to cite or link to this item:
|Title:||Modelling and estimating dynamics of tumor shrinkage with Blenx and KinferX|
|Source:||Lecca, P.,Kahramanoǧullari, O.,Morpurgo, D.,Priami, C.,Soo, R.A. (2011). Modelling and estimating dynamics of tumor shrinkage with Blenx and KinferX. Proceedings - 2011 UKSim 13th International Conference on Modelling and Simulation, UKSim 2011 : 75-80. ScholarBank@NUS Repository. https://doi.org/10.1109/UKSIM.2011.24|
|Abstract:||We present CoSBiLab BlenX as a development and analysis platform for modeling pharmacodynamical systems. Together with its supporting tool CoSBiLab KInfer for inferring kinetic parameters, BlenX provides an effective compromise between the differential equations-based and mechanisms-based approaches to modeling of pharmacodynamical systems. In this paper, we support this claim with models that describe the tumor size changes over the time course of chemotherapy in lung cancer patients treated with gemcitabine and carboplatin. Our first simple high-level model relies on a few identifiable and biologically relevant parameters. The estimation of these parameters requires only the tumor growth curve in vivo, typically available in the clinical setting. This model is an essential first step of our ongoing work where we aim at explaining the high-level behavior with our second model. This latter model incorporates the molecular machinery of the drug that determines the cytotoxic effect resulting in the shrinkage of the tumor. © 2011 IEEE.|
|Source Title:||Proceedings - 2011 UKSim 13th International Conference on Modelling and Simulation, UKSim 2011|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Mar 7, 2018
checked on Mar 9, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.